Exact Mass: 508.46891760000005

Exact Mass Matches: 508.46891760000005

Found 199 metabolites which its exact mass value is equals to given mass value 508.46891760000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Hydroxy-16,18-tritriacontanedione

4-Hydroxy-16,18-tritriacontanedione

C33H64O3 (508.48551940000004)


4-Hydroxy-16,18-tritriacontanedione is a constituent of the leaf waxes of Eucalyptus globulus (Tasmanian blue gum). Constituent of the leaf waxes of Eucalyptus globulus (Tasmanian blue gum)

   

FAHFA(16:1(9Z)/5-O-16:0)

5-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/5-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-POHPA since it is the 5-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/7-O-16:0)

7-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/7-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 7-hydroxyhexadecanoic acid. It is alternatively named 7-POHPA since it is the 7-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/8-O-16:0)

8-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/8-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 8-hydroxyhexadecanoic acid. It is alternatively named 8-POHPA since it is the 8-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/9-O-16:0)

9-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/9-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 9-hydroxyhexadecanoic acid. It is alternatively named 9-POHPA since it is the 9-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/10-O-16:0)

10-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/10-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 10-hydroxyhexadecanoic acid. It is alternatively named 10-POHPA since it is the 10-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/11-O-16:0)

11-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/11-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 11-hydroxyhexadecanoic acid. It is alternatively named 11-POHPA since it is the 11-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/12-O-16:0)

12-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/12-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 12-hydroxyhexadecanoic acid. It is alternatively named 12-POHPA since it is the 12-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/13-O-16:0)

13-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/13-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 13-hydroxyhexadecanoic acid. It is alternatively named 13-POHPA since it is the 13-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

FAHFA(16:1(9Z)/6-O-16:0)

6-[(9Z)-hexadec-9-enoyloxy]hexadecanoic acid

C32H60O4 (508.449136)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/6-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 6-hydroxyhexadecanoic acid. It is alternatively named 6-POHPA since it is the 6-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.

   

Alexidine

1-{N-[6-(N-{amino[N-(2-ethylhexyl)carbamimidamido]methylidene}amino)hexyl]carbamimidamido}-N-(2-ethylhexyl)methanimidamide

C26H56N10 (508.46891760000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   
   
   

(R)-5-hydroxy-tritriacontane-12,14-dione|5-hydroxy-tritriacontane-12,14-dione

(R)-5-hydroxy-tritriacontane-12,14-dione|5-hydroxy-tritriacontane-12,14-dione

C33H64O3 (508.48551940000004)


   

Tigloyl-10(30)-Taraxasten-3-ol

Tigloyl-10(30)-Taraxasten-3-ol

C35H56O2 (508.4280076)


   
   

Taraxasteroltiglinsaeureester|Tigloyl-20(30)-Taraxasten-3-ol

Taraxasteroltiglinsaeureester|Tigloyl-20(30)-Taraxasten-3-ol

C35H56O2 (508.4280076)


   
   
   
   

alexidine

alexidine

C26H56N10 (508.46891760000005)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

4-Hydroxy-16,18-tritriacontanedione

4-Hydroxy-16,18-tritriacontanedione

C33H64O3 (508.48551940000004)


   

FA 33:1;O

11-Oxotritriacontanoic acid

C33H64O3 (508.48551940000004)


   

5-POHPA

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

7-POHPA

7-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

8-POHPA

8-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

9-POHPA

9-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

10-POHPA

10-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

11-POHPA

11-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

12-POHPA

12-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

13-POHPA

13-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   

ditetradecyl but-2-enedioate

ditetradecyl but-2-enedioate

C32H60O4 (508.449136)


   

1,4-Cyclohexanediylbis(methylene) didodecanoate

1,4-Cyclohexanediylbis(methylene) didodecanoate

C32H60O4 (508.449136)


   

Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) sebacate

Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) sebacate

C30H56N2O4 (508.42398560000004)


   
   

(4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8,12,16,20,24-hexaenal

(4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8,12,16,20,24-hexaenal

C35H56O2 (508.4280076)


   

(4E)-9,11-dihydroxy-4-methyldotriacont-4-en-3-one

(4E)-9,11-dihydroxy-4-methyldotriacont-4-en-3-one

C33H64O3 (508.48551940000004)


   

[3-carboxy-2-[(13E,16E)-tetracosa-13,16-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(13E,16E)-tetracosa-13,16-dienoyl]oxypropyl]-trimethylazanium

C31H58NO4+ (508.43656080000005)


   

[3-carboxy-2-[(18Z,21E)-tetracosa-18,21-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(18Z,21E)-tetracosa-18,21-dienoyl]oxypropyl]-trimethylazanium

C31H58NO4+ (508.43656080000005)


   

2-Mohsa [dmed-fahfa]

2-Mohsa [dmed-fahfa]

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentanoate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonanoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonanoate

C32H60O4 (508.449136)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] propanoate

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] propanoate

C32H60O4 (508.449136)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptanoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C32H60O4 (508.449136)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-nonoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-nonoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C32H60O4 (508.449136)


   

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C32H60O4 (508.449136)


   

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] undecanoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] undecanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-tridecoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-hydroxy-3-tridecoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C32H60O4 (508.449136)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate

C32H60O4 (508.449136)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tridecanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tridecanoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C32H60O4 (508.449136)


   

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] decanoate

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] decanoate

C32H60O4 (508.449136)


   

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C32H60O4 (508.449136)


   
   
   
   

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-pentadec-9-enoate

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-pentadec-9-enoate

C35H56O2 (508.4280076)


   
   
   
   
   

Fahfa 21:1/11:0

Fahfa 21:1/11:0

C32H60O4 (508.449136)


   

Fahfa 11:0/21:1

Fahfa 11:0/21:1

C32H60O4 (508.449136)


   

Fahfa 15:1/17:0

Fahfa 15:1/17:0

C32H60O4 (508.449136)


   

Fahfa 13:0/19:1

Fahfa 13:0/19:1

C32H60O4 (508.449136)


   

Fahfa 16:0/16:1

Fahfa 16:0/16:1

C32H60O4 (508.449136)


   

Fahfa 18:0/14:1

Fahfa 18:0/14:1

C32H60O4 (508.449136)


   

Fahfa 13:1/19:0

Fahfa 13:1/19:0

C32H60O4 (508.449136)


   

Fahfa 14:0/18:1

Fahfa 14:0/18:1

C32H60O4 (508.449136)


   

Fahfa 17:1/15:0

Fahfa 17:1/15:0

C32H60O4 (508.449136)


   

Fahfa 10:0/22:1

Fahfa 10:0/22:1

C32H60O4 (508.449136)


   

Fahfa 22:1/10:0

Fahfa 22:1/10:0

C32H60O4 (508.449136)


   

Fahfa 12:0/20:1

Fahfa 12:0/20:1

C32H60O4 (508.449136)


   

Fahfa 17:0/15:1

Fahfa 17:0/15:1

C32H60O4 (508.449136)


   

Fahfa 20:1/12:0

Fahfa 20:1/12:0

C32H60O4 (508.449136)


   

Fahfa 19:0/13:1

Fahfa 19:0/13:1

C32H60O4 (508.449136)


   

Fahfa 15:0/17:1

Fahfa 15:0/17:1

C32H60O4 (508.449136)


   

Fahfa 19:1/13:0

Fahfa 19:1/13:0

C32H60O4 (508.449136)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

5-(9Z-hexadecenoyloxy)-hexadecanoic acid

C32H60O4 (508.449136)


   
   

FAHFA 10:0/O-22:1

FAHFA 10:0/O-22:1

C32H60O4 (508.449136)


   

FAHFA 10:1/O-22:0

FAHFA 10:1/O-22:0

C32H60O4 (508.449136)


   

FAHFA 11:0/O-21:1

FAHFA 11:0/O-21:1

C32H60O4 (508.449136)


   

FAHFA 11:1/O-21:0

FAHFA 11:1/O-21:0

C32H60O4 (508.449136)


   

FAHFA 12:0/O-20:1

FAHFA 12:0/O-20:1

C32H60O4 (508.449136)


   

FAHFA 12:1/O-20:0

FAHFA 12:1/O-20:0

C32H60O4 (508.449136)


   

FAHFA 13:0/O-19:1

FAHFA 13:0/O-19:1

C32H60O4 (508.449136)


   

FAHFA 13:1/O-19:0

FAHFA 13:1/O-19:0

C32H60O4 (508.449136)


   

FAHFA 14:0/O-18:1

FAHFA 14:0/O-18:1

C32H60O4 (508.449136)


   

FAHFA 14:1(9Z)/12O-18:0

FAHFA 14:1(9Z)/12O-18:0

C32H60O4 (508.449136)


   

FAHFA 14:1/O-18:0

FAHFA 14:1/O-18:0

C32H60O4 (508.449136)


   

FAHFA 15:0/O-17:1

FAHFA 15:0/O-17:1

C32H60O4 (508.449136)


   

FAHFA 15:1/O-17:0

FAHFA 15:1/O-17:0

C32H60O4 (508.449136)


   

FAHFA 16:0/O-16:1

FAHFA 16:0/O-16:1

C32H60O4 (508.449136)


   

FAHFA 16:1(9Z)/3O-16:0

FAHFA 16:1(9Z)/3O-16:0

C32H60O4 (508.449136)


   

FAHFA 16:1/O-16:0

FAHFA 16:1/O-16:0

C32H60O4 (508.449136)


   

FAHFA 17:0/O-15:1

FAHFA 17:0/O-15:1

C32H60O4 (508.449136)


   

FAHFA 17:1(9Z)/15O-15:0

FAHFA 17:1(9Z)/15O-15:0

C32H60O4 (508.449136)


   

FAHFA 17:1/O-15:0

FAHFA 17:1/O-15:0

C32H60O4 (508.449136)


   

FAHFA 18:0/O-14:1

FAHFA 18:0/O-14:1

C32H60O4 (508.449136)


   

FAHFA 18:1(9Z)/2O-14:0

FAHFA 18:1(9Z)/2O-14:0

C32H60O4 (508.449136)


   

FAHFA 18:1/O-14:0

FAHFA 18:1/O-14:0

C32H60O4 (508.449136)


   

FAHFA 19:0/O-13:1

FAHFA 19:0/O-13:1

C32H60O4 (508.449136)


   

FAHFA 19:1(10Z)/3O-13:0

FAHFA 19:1(10Z)/3O-13:0

C32H60O4 (508.449136)


   

FAHFA 19:1/O-13:0

FAHFA 19:1/O-13:0

C32H60O4 (508.449136)


   

FAHFA 20:0/O-12:1

FAHFA 20:0/O-12:1

C32H60O4 (508.449136)


   

FAHFA 20:1(11Z)/3O-12:0

FAHFA 20:1(11Z)/3O-12:0

C32H60O4 (508.449136)


   

FAHFA 20:1/O-12:0

FAHFA 20:1/O-12:0

C32H60O4 (508.449136)


   

FAHFA 21:0/O-11:1

FAHFA 21:0/O-11:1

C32H60O4 (508.449136)


   

FAHFA 21:1/O-11:0

FAHFA 21:1/O-11:0

C32H60O4 (508.449136)


   

FAHFA 22:0/O-10:1

FAHFA 22:0/O-10:1

C32H60O4 (508.449136)


   

FAHFA 22:1(13Z)/3O-10:0

FAHFA 22:1(13Z)/3O-10:0

C32H60O4 (508.449136)


   

FAHFA 22:1/O-10:0

FAHFA 22:1/O-10:0

C32H60O4 (508.449136)


   

FAHFA 23:0/O-9:1

FAHFA 23:0/O-9:1

C32H60O4 (508.449136)


   

FAHFA 23:1(14Z)/3O-9:0

FAHFA 23:1(14Z)/3O-9:0

C32H60O4 (508.449136)


   

FAHFA 23:1/O-9:0

FAHFA 23:1/O-9:0

C32H60O4 (508.449136)


   

FAHFA 24:0/O-8:1

FAHFA 24:0/O-8:1

C32H60O4 (508.449136)


   

FAHFA 24:1(15Z)/3O-8:0

FAHFA 24:1(15Z)/3O-8:0

C32H60O4 (508.449136)


   

FAHFA 24:1/O-8:0

FAHFA 24:1/O-8:0

C32H60O4 (508.449136)


   

FAHFA 8:0/O-24:1

FAHFA 8:0/O-24:1

C32H60O4 (508.449136)


   

FAHFA 8:1/O-24:0

FAHFA 8:1/O-24:0

C32H60O4 (508.449136)


   

FAHFA 9:0/O-23:1

FAHFA 9:0/O-23:1

C32H60O4 (508.449136)


   

FAHFA 9:1/O-23:0

FAHFA 9:1/O-23:0

C32H60O4 (508.449136)


   
   
   
   
   

(5r)-5-hydroxytritriacontane-12,14-dione

(5r)-5-hydroxytritriacontane-12,14-dione

C33H64O3 (508.48551940000004)


   

1,9,13-trimethyl-8-pentadecyl-1,5,9,13-tetraazacycloheptadec-5-en-6-ol

1,9,13-trimethyl-8-pentadecyl-1,5,9,13-tetraazacycloheptadec-5-en-6-ol

C31H64N4O (508.5079854)


   
   

(5s)-5-hydroxytritriacontane-12,14-dione

(5s)-5-hydroxytritriacontane-12,14-dione

C33H64O3 (508.48551940000004)


   

10-ethenyl-21-isopropyl-2,3,7,10,13,16,20-heptamethyl-6,17-dimethylidenetricosa-1,11,21-triene

10-ethenyl-21-isopropyl-2,3,7,10,13,16,20-heptamethyl-6,17-dimethylidenetricosa-1,11,21-triene

C37H64 (508.5007744)


   

(3r,7r,10s,11e,13r,16r,20r,21z)-10-ethenyl-21-isopropyl-2,3,7,10,13,16,20-heptamethyl-6,17-dimethylidenetricosa-1,11,21-triene

(3r,7r,10s,11e,13r,16r,20r,21z)-10-ethenyl-21-isopropyl-2,3,7,10,13,16,20-heptamethyl-6,17-dimethylidenetricosa-1,11,21-triene

C37H64 (508.5007744)


   

5-hydroxytritriacontane-12,14-dione

5-hydroxytritriacontane-12,14-dione

C33H64O3 (508.48551940000004)


   

(8r)-1,9,13-trimethyl-8-pentadecyl-1,5,9,13-tetraazacycloheptadec-5-en-6-ol

(8r)-1,9,13-trimethyl-8-pentadecyl-1,5,9,13-tetraazacycloheptadec-5-en-6-ol

C31H64N4O (508.5079854)